An observational study in Psoas Tendinitis, sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-03.
Sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche · Observational
Evaluation of predictive factors for psoas tendinitis after first-line total hip arthroplasty.
A single-centre retrospective study of medical data from the medical records of patients undergoing total hip arthroplasty.
From the medical records of a series of patients operated on for total hip arthroplasty:
Main objective: To assess individual and surgical factors associated with the development of psoas tendinitis.
Secondary objectives:
413 studies on the registry are indexed under Tendinopathy; 64 are open to participants now.
This study's enrollment of 1,199 is above the median of 67 across 52 observational studies indexed under Tendinopathy.
Browse Tendinopathy studies →GCS Ramsay Santé pour l'Enseignement et la Recherche is the lead sponsor of 198 studies on the registry; 94 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients who have had a total hip replacement for at least six months.
Exclusion Criteria:
Simple cohort
Other: Cohort
Cohort
Psoas tendinitis development
Pain remission after tenotomy.
Time frame: 6 months
Psoas tendinitis occurrence frequency
Frequency of occurrence of psoas tendinitis
Time frame: 6 months
To describe the outcome of patients who have undergone tenotomy
To describe the outcome of patients who have undergone tenotomy
Time frame: 6 months
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
GCS Ramsay Santé pour l'Enseignement et la Recherche